Johnson & Johnson: Extended Wave 3 Nearing Completion, Watching Johnson & Johnson is showing a very nice recovery with clear impulsive price action since breaking out of the downward channel back in July. The structure suggests an ongoing trend with an extended black wave three that now has five waves up as expected, after a nice fourth wave retracement to 186 i
Key facts today
Johnson & Johnson has acquired Halda Therapeutics for $3.05 billion, enhancing its oncology pipeline, especially for advanced prostate cancer treatments.
Johnson & Johnson plans to boost U.S. investments by 25%, totaling $55 billion over four years, including four new plants in North Carolina.
1.43 CAD
19.27 B CAD
121.68 B CAD
About Johnson & Johnson
Sector
Industry
CEO
Joaquin Duato
Website
Headquarters
New Brunswick
Founded
1887
ISIN
CA47817E1034
FIGI
BBG01JDLZ9R9
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Related stocks
Johnson & Johnson Wave Analysis – 14 November 2025- Johnson & Johnson broke pivotal resistance level 194.00
- Likely to rise to resistance level 200.00
Johnson & Johnson recently broke above the pivotal resistance level 194.00, which stopped the previous impulse wave (3) in the middle of October.
The breakout of the resistance level 194.00 accel
Johnson & Johnson (JNJ) Finds Support at Key Level Johnson & Johnson (JNJ) continues to demonstrate strong defensive positioning and renewed momentum as structural shifts in its business and improving sentiment fuel a breakout from a multiyear downtrend. After the successful separation of its consumer health arm, J&J is now more focused on its pharm
Bear Call Spread on JNJBear Call Spread Sell 195 Call strike and Buy 200 Call Strike, Exp: Nov 28 (45 DTE) for no less than $1.55
Trade has about 67% probability of profit
Taking advantage of high IV rank of 40
Credit received = $155
BP Effect = $345
Max Loss = (5 - 1.55) * 100 = $345
Breakeven = 195 + 1.55 = $196.55
Johnson & Johnson. Clean. Soft. Gentle. Growth.Johnson & Johnson (JNJ) stands out as a bellwether in the global healthcare sector, and its nearly 18% stock performance in 2025 reflects both robust fundamentals and compelling technical trends.
Fundamental Perspective
JNJ maintains a solid financial foundation, underpinned by consistently st
JNJ Undervalued with Strong Fundamentals Pharma Giant?JNJ – Financial Performance & SWOT Analysis
JNJ Undervalued with Strong Fundamentals Pharma Giant?
(1/9)
Good morning, folks! JNJ is steady 📈, at $ 191.08 up 35.31% YTD per October 10, 2025. Q2 revenue shakes up this pharma play , let’s dive in! 📊🔥 Tag a friend who needs this investing hack!
(2
JNJ is unchainedJNJ is unchained
JNJ has spent 4 years moving sideways, which basically means the market agreed this was the fair price f or the stock.
But this August, we saw analysts like Joanne Wuensch from Citi start pointing to the $200 zone , and it looks like she might have been right. 🚀
If you missed
Johnson & Johnson Bulls Break the FlagJohnson & Johnson has been in a strong uptrend, with buyers consistently driving price higher. After the impulsive rally, price consolidated into a downward-sloping flag, where sellers tried to take control but failed to push lower. Buyers then stepped back in, breaking out of the flag with strength
Band-Aids to Blowouts: Shorting J&J's This short trade is based on the idea that JNJ's stock price has extended beyond a long-term upward channel, suggesting a high-probability mean reversion or correction back toward the established trendline. The chart suggests a bearish divergence or a temporary blow-off top scenario. The price has a
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US478160CM4
Johnson & Johnson 3.5% 15-JAN-2048Yield to maturity
5.27%
Maturity date
Jan 15, 2048
JNJJ
Johnson & Johnson 3.75% 03-MAR-2047Yield to maturity
5.25%
Maturity date
Mar 3, 2047
US478160CX0
Johnson & Johnson 5.25% 01-JUN-2054Yield to maturity
5.24%
Maturity date
Jun 1, 2054
US478160CS1
Johnson & Johnson 2.25% 01-SEP-2050Yield to maturity
5.23%
Maturity date
Sep 1, 2050
US478160BV5
Johnson & Johnson 3.7% 01-MAR-2046Yield to maturity
5.21%
Maturity date
Mar 1, 2046
US478160CT9
Johnson & Johnson 2.45% 01-SEP-2060Yield to maturity
5.20%
Maturity date
Sep 1, 2060
JNJ4077469
Johnson & Johnson 4.5% 05-DEC-2043Yield to maturity
5.09%
Maturity date
Dec 5, 2043
US478160CR3
Johnson & Johnson 2.1% 01-SEP-2040Yield to maturity
5.00%
Maturity date
Sep 1, 2040
US478160BA1
Johnson & Johnson 4.85% 15-MAY-2041Yield to maturity
4.98%
Maturity date
May 15, 2041
JNJ.GT
Johnson & Johnson 4.5% 01-SEP-2040Yield to maturity
4.82%
Maturity date
Sep 1, 2040
US478160CL6
Johnson & Johnson 3.4% 15-JAN-2038Yield to maturity
4.75%
Maturity date
Jan 15, 2038
See all JNJ bonds
Curated watchlists where JNJ is featured.
















